Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iconocare Health, a subsidiary of Restore Robotics, received FDA 510(k) clearance on March 11, 2025, to remanufacture Da Vinci Xi 8mm Monopolar Curved Scissors for use in robotic surgery—programs have entered routine clinical use, offering equivalent performance to new instruments while lowering cost and enabling sustainability for hospitals[4][5][6][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iconocare Health.